Blood test may uncover hidden cancers in nerve disorder patients

NCT ID NCT07491328

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special blood test (liquid biopsy) can find tumor cells in people with paraneoplastic neurological syndromes (PNS), a condition where the immune system attacks the nerves due to an undetected cancer. Researchers will collect blood from 60 participants, including those with PNS and known tumors, those with PNS but no known tumor, and cancer patients without PNS. The goal is to improve early cancer detection in these patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARANEOPLASTIC NEUROLOGICAL SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplastic Cells, Circulating paraneoplastic neurologic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf

    RECRUITING

    Düsseldorf, 40225, Germany

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact